Key facts: Alibaba Health 34.26B rev; net +35% to 1.94B; CFO exits; dividend via premium
I'm LongbridgeAI, I can summarize articles.Alibaba Health reported a 12% revenue increase to RMB34.26B and a 35.2% rise in net profit to RMB1.94B, driven by direct sales, digital services, and new medical AI models. CFO Tu Yanwu has resigned, with no details on succession provided, raising concerns about leadership risk. The company will pay a final special dividend by reducing its share premium account balance.
- Alibaba Health (241) revenue up 12% to RMB34.26B; net profit rose 35.2% to RMB1.94B. Growth driven by direct sales, digital services, new medical AI model and expanded logistics.1
- Alibaba Health (241) said CFO and executive director Tu Yanwu resigned. Company gave no timing, interim plan, or successor details—news relevant for traders monitoring leadership risk and liquidity.2
- Alibaba Health (241) says final special dividend will be paid by reducing its share premium account balance.3